{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T10:22:20Z","timestamp":1779358940119,"version":"3.51.4"},"reference-count":31,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","dldjournalonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.dld.2018.10.018","type":"journal-article","created":{"date-parts":[[2018,11,3]],"date-time":"2018-11-03T12:19:12Z","timestamp":1541247552000},"page":"712-718","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Long-term follow-up of children and young adults with autoimmune hepatitis treated with cyclosporine"],"prefix":"10.1016","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0200-5326","authenticated-orcid":false,"given":"Silvia","family":"Nastasio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4092-9071","authenticated-orcid":false,"given":"Marco","family":"Sciveres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7635-3791","authenticated-orcid":false,"given":"Lorenza","family":"Matarazzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Malaventura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Cirillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Riva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8201-2416","authenticated-orcid":false,"given":"Giuseppe","family":"Maggiore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2018.10.018_bib0005","doi-asserted-by":"crossref","first-page":"464","DOI":"10.4254\/wjh.v6.i7.464","article-title":"Juvenile autoimmune hepatitis: spectrum of the disease","volume":"6","author":"Maggiore","year":"2014","journal-title":"World J Hepatol"},{"key":"10.1016\/j.dld.2018.10.018_bib0010","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/hep.510250308","article-title":"Autoimmune hepatitis in childhood: a 20-year experience","volume":"25","author":"Gregorio","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2018.10.018_bib0015","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0022-3476(84)80477-1","article-title":"Treatment of autoimmune chronic active hepatitis in childhood","volume":"104","author":"Maggiore","year":"1984","journal-title":"J Pediatr"},{"key":"10.1016\/j.dld.2018.10.018_bib0020","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0140-6736(73)92125-9","article-title":"Controlled trial of prednisone and azathioprine in active chronic hepatitis","volume":"1","author":"Murray-Lyon","year":"1973","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2018.10.018_bib0025","first-page":"655","article-title":"Life-saving immunosuppressive treatment in severe autoimmune chronic active hepatitis","volume":"4","author":"Maggiore","year":"1985","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.dld.2018.10.018_bib0030","doi-asserted-by":"crossref","first-page":"463","DOI":"10.5694\/j.1326-5377.1985.tb123140.x","article-title":"Cyclosporin, a new treatment for autoimmune chronic active hepatitis","volume":"143","author":"Mistilis","year":"1985","journal-title":"Med J Aust"},{"key":"10.1016\/j.dld.2018.10.018_bib0035","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/0016-5085(87)90454-9","article-title":"Cyclosporine treatment of autoimmune chronic active hepatitis","volume":"93","author":"Hyams","year":"1987","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2018.10.018_bib0040","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S0168-8278(99)80065-8","article-title":"Short-term cyclosporine induces a remission of autoimmune hepatitis in children","volume":"30","author":"Alvarez","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2018.10.018_bib0045","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0022-3476(99)70339-2","article-title":"Efficacy of cyclosporin A in children with type 2 autoimmune hepatitis","volume":"135","author":"Debray","year":"1999","journal-title":"J Pediatr"},{"key":"10.1016\/j.dld.2018.10.018_bib0050","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/01.mpg.0000235975.75120.38","article-title":"Follow-up of children with autoimmune hepatitis treated with cyclosporine","volume":"43","author":"Cuarterolo","year":"2006","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.dld.2018.10.018_bib0055","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.cgh.2010.10.013","article-title":"Immunosuppressive therapy allows recovery from liver failure in children with autoimmune hepatitis","volume":"9","author":"Cuarterolo","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2018.10.018_bib0060","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1046\/j.1365-2036.2003.01754.x","article-title":"Effectiveness and safety of ciclosporin as therapy for autoimmune diseases of the liver in children and adolescents","volume":"19","author":"Sciveres","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2018.10.018_bib0065","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","article-title":"Histological grading and staging of chronic hepatitis","volume":"22","author":"Ishak","year":"1995","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2018.10.018_bib0070","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2018.10.018_bib0075","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jhep.2015.06.030","article-title":"EASL clinical practice guidelines: autoimmune hepatitis","volume":"63","author":"European Association for the Study of the Liver","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2018.10.018_bib0080","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1046\/j.1440-1746.2001.02615.x","article-title":"Long-term outcome of autoimmune hepatitis in children","volume":"16","author":"Saadah","year":"2001","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2018.10.018_bib0085","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.dld.2010.01.002","article-title":"Autoimmune hepatitis in children-impact of cirrhosis at presentation on natural history and long-term outcome","volume":"42","author":"Radhakrishnan","year":"2010","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.dld.2018.10.018_bib0090","first-page":"376","article-title":"Autoimmune hepatitis associated with anti-actin antibodies in children and adolescents","volume":"17","author":"Maggiore","year":"1993","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.dld.2018.10.018_bib0095","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0022-3476(86)80880-0","article-title":"Liver disease associated with anti-liver-kidney microsome antibody in children","volume":"108","author":"Maggiore","year":"1986","journal-title":"J Pediatr"},{"key":"10.1016\/j.dld.2018.10.018_bib0100","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1007\/s10620-012-2151-2","article-title":"Advances in the current treatment of autoimmune hepatitis","volume":"57","author":"Czaja","year":"2012","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.dld.2018.10.018_bib0105","first-page":"771","article-title":"Tacrolimus: a potential new treatment for autoimmune chronic active hepatitis: results of an open-label preliminary trial","volume":"90","author":"Van Thiel","year":"1995","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2018.10.018_bib0110","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/S0168-8278(98)80128-1","article-title":"Successful treatment of refractory type 1 AIH with methotrexate","volume":"29","author":"Burak","year":"1998","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2018.10.018_bib0115","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0168-8278(00)80271-8","article-title":"Mycophenolate mofetil for maintenance of remission in autoimmune hepatitis in patients resistant to or intolerant of azathioprine","volume":"33","author":"Richardson","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2018.10.018_bib0120","first-page":"1345","article-title":"Cyclosporin A in non-transplant-related liver diseases","volume":"84","author":"Minuk","year":"1989","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2018.10.018_bib0125","first-page":"270","article-title":"Cyclosporine therapy for gastrointestinal disease","volume":"18","author":"Treem","year":"1994","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.dld.2018.10.018_bib0130","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0272-6386(00)70348-9","article-title":"Nephrotoxicity of immunosuppressive drugs: long-term consequences and challenges for the future","volume":"35","author":"Mattos","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.dld.2018.10.018_bib0135","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1053\/j.ajkd.2008.11.033","article-title":"Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial","volume":"53","author":"Choudhry","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.dld.2018.10.018_bib0140","doi-asserted-by":"crossref","first-page":"e1237","DOI":"10.1542\/peds.2015-0578","article-title":"Incidence and characteristics of autoimmune hepatitis","volume":"136","author":"Jim\u00e9nez-Rivera","year":"2015","journal-title":"Pediatrics"},{"key":"10.1016\/j.dld.2018.10.018_bib0145","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/s12072-014-9558-0","article-title":"Characteristics and outcome of autoimmune liver disease in Asian children","volume":"9","author":"Lee","year":"2015","journal-title":"Hepatol Int"},{"key":"10.1016\/j.dld.2018.10.018_bib0150","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/MPG.0000000000001530","article-title":"Second-line agents in pediatric patients with autoimmune hepatitis: a systematic review and meta-analysis","volume":"65","author":"Zizzo","year":"2017","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.dld.2018.10.018_bib0155","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/MPG.0000000000001801","article-title":"Diagnosis and management of pediatric autoimmune liver disease: ESPGHAN hepatology committee position statement","volume":"66","author":"Mieli-Vergani","year":"2018","journal-title":"J Pediatr Gastroenterol Nutr"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865818312143?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865818312143?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:10:34Z","timestamp":1761624634000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865818312143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S1590865818312143"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2018.10.018","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term follow-up of children and young adults with autoimmune hepatitis treated with cyclosporine","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2018.10.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}